drugset / Trial / NCT01184456

A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System

NCT01184456

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Improvement in the rate of bacterial translocation may lead to a decrease in a chronic inflammatory response thereby decreasing CD4 destruction and HIV proliferation. By the addition of probiotics we hope to show a reduction in LPS leading to a decrease in chronic inflammation and therefore an improvement in immune markers.

Timeline

Start
2010-08
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Bacillus coagulans Other / unclassified 2e+09 unknown